Clinical trial · Observational
Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis
Differential Diagnosis Between Pancreatic Cancer and Chronic Pancreatitis: Value of the Detection of Urinary Cadmium
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Measuring cadmium levels in urine samples from patients with chronic pancreatitis may help doctors predict which patients may develop pancreatic cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is studying urine cadmium levels in predicting pancreatic cancer risk in patients with chronic pancreatitis.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
| Precancerous Condition | Pancreatic Neoplasm | PROBABILISTIC | 0.70 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- pre cancerous condition (pancreatitis)
Primary outcomes (2)
- measure
- Exposure to cadmium, as measured by questionnaire data on dietary, occupational, and recreational exposure to cadmium, and by measurements of cadmium in urine
- timeFrame
- day 1
- measure
- Risk of pancreatic cancer as determined by urine cadmium levels
- timeFrame
- day 1
Secondary outcomes (2)
- measure
- Predictive value of urinary cadmium on development of pancreatic cancer
- timeFrame
- day 1
- measure
- Predictive value of urinary cadmium alone, CA 19-9 alone, and both tests together on development of pancreatic cancer
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 120 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Clinical diagnosis of chronic pancreatitis * Being seen in the Department of Gastroenterology at Wake Forest University Baptist Medical Center PATIENT CHARACTERISTICS: * No type II diabetes * Able to understand and respond to questionnaire * Able to provide urine specimen * Speaks English PRIOR CONCURRENT THERAPY: * Not specified
References
Publications (0)
Data not yet available